Stay updated on TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.

Latest updates to the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedRevision updated to v3.0.2. It removes the MedlinePlus Genetics topic on Multiple myeloma and the older v3.0.1 entry (as well as the Back to Top link).SummaryDifference0.4%
- Check9 days agoChange DetectedThe web page has been updated to include information on 'Multiple myeloma' under MedlinePlus Genetics topics, and the version has been revised from v3.0.0 to v3.0.1.SummaryDifference0.4%
- Check16 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location related to plasma cell myeloma and hemic and lymphatic diseases, while several specific location details and drug information have been removed.SummaryDifference2%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1.0%
Stay in the know with updates to TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.